Opinion: An Explosion of Devices

From cardiovascular problems to neurological disorders, a plethora of new medical devices are reducing the need for surgery and improving the quality and safety of healthcare.

Written byStephen C. Schimpff
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, MRARIFNAJAFOV We tend to think of medical advances emanating from the basic and translational research performed by scientists in universities, the pharmaceutical industry, and the National Institutes of Health. But we should not forget that the medical device industry is also exceptionally entrepreneurial and dynamic, constantly developing new technologies off the back of major advances in computer and engineering science. More often than not, these new technologies not only improve the quality and safety of medical care, but can also reduce the costs when used appropriately.

Among the new devices recently introduced is a catheter-based device developed by Edwards Lifesciences in Irvine, California, that can perform an aortic valve replacement. Aortic stenosis—when the aortic valve does not fully open—is not uncommon in older individuals, and cases are on the rise as the population ages. Once the first symptoms develop, about 50 percent of patients will die within 2 years. Surgical replacement of the aortic valve improves both heart function and survival, but about 30 percent of aortic stenosis patients are not surgical candidates due to age or other diseases. Thankfully, this new device can be inserted without open surgery. The catheter goes into the major artery in the groin and advances to the heart, where the old valve is broken open ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies